Evidence map›Paper›PMID 32892240›Full record

ArticleJournal of bone and mineral metabolism2020

Executive summary of clinical practice guide on fracture risk in lifestyle diseases.

Ippei Kanazawa, Masaaki Inaba, Daisuke Inoue, Kazuhiro Uenishi, Mitsuru Saito, Masataka Shiraki, Atsushi Suzuki, Yasuhiro Takeuchi, Hiroshi Hagino, Saeko Fujiwara and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of bone and mineral metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. The impact of chronic obstructive pulmonary disease on bone strength.Journal of bone and mineral metabolism · 2024
    Review
  10. Association of depressive symptoms with incident fractures: the Japan Public Health Center-based Prospective Study for the Next Generation (JPHC-NEXT).Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2024
    Article
  11. Review
  12. Observational
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ippei KanazawaKanazawa Diabetes and Osteoporosis Clinic, 990-2-1 Enya-cho, Izumo, Shimane, 693-0021, Japan. ippeikanazawa@kanazawa-doc.com.ORCID http://orcid.org/0000-0001-9001-5609
Masaaki InabaDepartment of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.
Daisuke InoueThird Department of Medicine, Teikyo University Chiba Medical Center, Chiba, Japan.
Kazuhiro UenishiDivision of Nutritional Physiology, Kagawa Nutrition University, Saitama, Japan.
Mitsuru SaitoDepartment of Orthopaedic Surgery, Jikei University School of Medicine, Tokyo, Japan.
Masataka ShirakiResearch Institute and Practice for Involutional Diseases, Nagano, Japan.
Atsushi SuzukiDepartment of Endocrinology and Metabolism, Fujita Health University, Aichi, Japan.
Yasuhiro TakeuchiEndocrine Center, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
Hiroshi HaginoSchool of Health Science Faculty of Medicine, Tottori University, Tottori, Japan.
Saeko FujiwaraDepartment of Pharmacy, Yasuda Women's University, Hiroshima, Japan.
Toshitsugu SugimotoEikokai Ono Hospital, Hyogo, Japan.
from the Japan Osteoporosis Society Lifestyle diseases-related Fracture Risk Investigation Committee

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating evidence has shown that patients with lifestyle diseases such as type 2 diabetes mellitus, chronic kidney disease, and chronic obstructive pulmonary disease are at increased risk of osteoporotic fracture. Fractures deteriorate quality of life, activities of daily living, and mortality as well as a lifestyle disease. Therefore, preventing fracture is an important issue for those patients. Although the mechanism of the lifestyle diseases-induced bone fragility is still unclear, not only bone mineral density (BMD) reduction but also bone quality deterioration are involved in it. Because fracture predictive ability of BMD and FRAX

Indexed as

DiseaseLife StylePractice Guidelines as TopicBone Density Conservation AgentsDiabetes Mellitus, Type 2HumansOsteoporotic FracturesPulmonary Disease, Chronic ObstructiveRenal Insufficiency, ChronicRisk AssessmentRisk FactorsBone Density Conservation AgentsBone qualityChronic kidney diseaseChronic obstructive pulmonary diseaseDiabetes mellitusGuide

Identifiers

PMID32892240

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.